CYBB and chronic granulomatous disease: Because NOX2-deficiency aggravates the infectious challenge caused by increased loads of intracellular S. aureus in BMDM, we tested adjunctive rifampicin treatment to reveal a potential benefit of targeting intracellular S. aureus in NOX2-related disorders like CGD.